Loss of the Ras Regulator RASAL1: Another Route to Ras Activation in Colorectal Cancer

Gastroenterology

Volumn 136, Issue 1, 2009, Pages 46-48

  Bernards, André ^a   Settleman, Jeffrey ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PROTEIN RASAL1; RAS PROTEIN; UNCLASSIFIED DRUG;

CANCER SURVIVAL; COLORECTAL CANCER; DISEASE COURSE; EDITORIAL; ENZYME ACTIVATION; ENZYME REGULATION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; CHEMISTRY; COLORECTAL TUMOR; NOTE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

COLORECTAL NEOPLASMS; HUMANS; RAS GTPASE-ACTIVATING PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 59849100942     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.11.024     Document Type: Editorial

References (23)

1. Parada L.F., Tabin C.J., Shih C., et al. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297 (1982) 474-478
2. Bos J.L., Fearon E.R., Hamilton S.R., et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 327 (1987) 293-297
3. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
4. Rodriguez-Viciana P., Sabatier C., et al. Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol 24 (2004) 4943-4954
5. Davies H., Bignell G.R., Cox C., et al. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
6. Rajagopalan H., Bardelli A., Lengauer C., et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418 (2002) 934
7. Samuels Y., Wang Z., Bardelli A., et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304 (2004) 554
8. Bernards A., and Settleman J. GEFs in growth factor signaling. Growth Factors 25 (2007) 355-361
9. Bernards A., and Settleman J. GAPs in growth factor signalling. Growth Factors 23 (2005) 143-149
10. Roberts A.E., Araki T., Swanson K.D., et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 39 (2007) 70-74
11. Tartaglia M., Pennacchio L.A., Zhao C., et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39 (2007) 75-79
12. Aoki Y., Niihori T., Narumi Y., et al. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat 29 (2008) 992-1006
13. Cichowski K., and Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104 (2001) 593-604
14. McLendon R., Friedman A., Bigner D., et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008)
15. Wood L.D., Parsons D.W., Jones S., et al. The genomic landscapes of human breast and colorectal cancers. Science 318 (2007) 1108-1113
16. Chen H., Toyooka S., Gazdar A.F., and Hsieh J.T. Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J Biol Chem 278 (2003) 3121-3130
17. Dote H., Toyooka S., Tsukuda K., et al. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. Clin Cancer Res 10 (2004) 2082-2089
18. Dote H., Toyooka S., Tsukuda K., et al. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. Br J Cancer 92 (2005) 1117-1125
19. Yano M., Toyooka S., Tsukuda K., et al. Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. Int J Cancer 113 (2005) 59-66
20. Qiu G.H., Xie H., Wheelhouse N., et al. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma. J Hepatol 46 (2007) 655-663
21. Ohta M., Seto M., Ijichi H., et al. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Gastroenterology 136 (2009) 206-216
22. Bernards A. Ras superfamily and interacting proteins database. Methods Enzymol 407 (2006) 1-9
23. Chen H., Tu S.W., and Hsieh J.T. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. J Biol Chem 280 (2005) 22437-22444